These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12566371)

  • 1. Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies.
    Ruggenenti P; Mise N; Pisoni R; Arnoldi F; Pezzotta A; Perna A; Cattaneo D; Remuzzi G
    Circulation; 2003 Feb; 107(4):586-92. PubMed ID: 12566371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?
    Vogt L; Navis G; de Zeeuw D
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S53-7. PubMed ID: 15938035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual renin-angiotensin system blockade at optimal doses for proteinuria.
    Laverman GD; Navis G; Henning RH; de Jong PE; de Zeeuw D
    Kidney Int; 2002 Sep; 62(3):1020-5. PubMed ID: 12164886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL; Ekhlas A; Nguyen JM; Moranne O
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin.
    Krikken JA; Waanders F; Dallinga-Thie GM; Dikkeschei LD; Vogt L; Navis GJ; Dullaart RP
    Expert Opin Ther Targets; 2009 May; 13(5):497-504. PubMed ID: 19397474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
    Massie BM; Armstrong PW; Cleland JG; Horowitz JD; Packer M; Poole-Wilson PA; Rydén L
    Arch Intern Med; 2001 Jan; 161(2):165-71. PubMed ID: 11176729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia is secondary to proteinuria and is completely normalized by angiotensin-converting enzyme inhibition in hypertensive fawn-hooded rats.
    Verseput GH; Provoost AP; van Tol A; Koomans HA; Joles JA
    Nephron; 1997; 77(3):346-52. PubMed ID: 9375831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.
    Heeg JE; de Jong PE; van der Hem GK; de Zeeuw D
    Kidney Int; 1989 Aug; 36(2):272-9. PubMed ID: 2550696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
    Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
    Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.
    Keilani T; Schlueter WA; Levin ML; Batlle DC
    Ann Intern Med; 1993 Feb; 118(4):246-54. PubMed ID: 8420442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statin therapy added to ACE-inhibitors on blood pressure control and endothelial functions in normolipidemic hypertensive patients.
    Danaoğlu Z; Kültürsay H; Kayikçioğlu M; Can L; Payzin S
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):331-7. PubMed ID: 14675884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Ueda S; Fukami K; Okuda S; Yamagishi S
    Pharmacol Res; 2010 Jan; 61(1):58-61. PubMed ID: 19666118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving remission of proteinuria in childhood CKD.
    Ruggenenti P; Cravedi P; Chianca A; Caruso M; Remuzzi G
    Pediatr Nephrol; 2017 Feb; 32(2):321-330. PubMed ID: 27704256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study.
    Janssen JJ; Gans RO; van der Meulen J; Pijpers R; ter Wee PM
    Am J Hypertens; 1998 Sep; 11(9):1074-9. PubMed ID: 9752892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
    Kanno Y; Takenaka T; Nakamura T; Suzuki H
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.